Development and
Cooperation

Digital monthly 6/2021

Pharma supply

: Children in poor countries have a much lower chance of surviving cancer than children in rich countries: Young cancer patients in Dhaka, Bangladesh
Cancer

Unaffordable treatment

For people in developing countries, most cancer drugs are unaffordable

Price negotiations

Paying over the odds

Thrashing out a vaccines pricing deal with multiple players

Mural in Soweto in 2002: HIV/AIDS was an increasingly devastating disease in southern Africa at the turn of the Millennium.
Multilateral affairs

Brief history of WTO flexibility regarding pharma patents

Why the international intellectual-property regime was modified in 2001

More Articles

“The USA has been hoarding vaccines rather than helping other nations to get inoculated”: Joe Biden got his first jab as president-elect before Christmas.
Pandemic response

Many governments are half-hearted about IP waiver

Debate on patent waiver for Covid-19 vaccines lacks sense of urgency

Pharmacist Elke Althöfer-Blautzik on an emergency mission to Mozambique in 2019.
Pharmacists in development cooperation

Essential experts

Pharmacists without borders do important work in aid missions and projects worldwide

Delivery of Covid-19 vaccine to South Sudan in March 2021 under the COVAX initiative – but experts say COVAX is delivering far too little vaccines worldwide.
Patents

Intellectual property versus health care

Insistence on medical patents costs lives, especially in the global south

People lining up in the Indian city of Pune to buy Remdesivir in April 2021.
Industry strategies

Repurposing offers rays of hope

How finding new uses for established pharmaceuticals matters in the fight against Covid-19

Illegal and counterfeit medicines seized by German customs officers.
Crime

Counterfeit medicines are very profitable for criminals

Hundreds of thousands of people die every year as a result of counterfeit medicines

IRC staff member taking off his personal protective equipment during Ebola outbreak in Goma in 2019.
Ebola and Covid-19

Lessons learned from Ebola and Covid-19

In the fight against a deadly disease, more things matter than only vaccines and pharmaceuticals

Precious asset: technicians in Nairobi with a carton of AstraZeneca Covid-19 vaccine manufactured by the Serum Institute of India.
Intellectual property

INGO opposes vaccine patents

Oxfam explains how current pricing and distribution of Covid-19 vaccines highlight global inequality

Kenyan nurse.
Our view

In the health sector, government action is indispensable

Unrestrained market forces do not deliver good health-care results

Everyone must play their part: Covid-19 awareness billboard in Lagos in spring 2020.
IMF

IMF keeps pressing for more assertive government action

IMF proposes investments worth $ 50 billion to boost Covid-19 vaccination programmes

In rural areas of Malawi, medicines and supplies often do not reach the intended recipients.
Rural health care

Medicines and supplies are difficult to find in rural Malawi

Rural Malawians are poorly served by clinics lacking medicines and expertise

Desmond Tutu, archbishop emeritus, gestures after receiving a vaccine shot in Cape Town in May.
Health care

Africans are learning lessons from other world regions

An expert from Cape Town assesses the state of African vaccination campaigns in view of coronavirus